Apogee Therapeutics Price Chart
Apogee Therapeutics Volume Chart
Apogee Therapeutics Market Segments
Premarket
*No Trades in Segment
Overnight
*No Trades in Segment
After Hours Yesterday
| Open | $132.64 |
|---|---|
| Close | $132.55 |
| Low | $132.55 |
| Low Change | -0.09 (-0.07%) |
| High | $132.87 |
| High Change | +0.23 (+0.17%) |
| Range | $0.32 |
| Volume | 1.141M |
| Dollar Volume | $151.20M |
Regular Trading Hours Yesterday
| Open | $132.79 |
|---|---|
| Close | $132.62 |
| Low | $132.60 |
| Low Change | -0.19 (-0.14%) |
| High | $132.87 |
| High Change | +0.08 (+0.06%) |
| Range | $0.27 |
| Volume | 3.94M |
| Dollar Volume | $522.59M |
Premarket Yesterday
| Open | $132.54 |
|---|---|
| Close | $133.19 |
| Low | $132.54 |
| Low Change | 0.00 (0.00%) |
| High | $133.56 |
| High Change | +1.02 (+0.77%) |
| Range | $1.02 |
| Volume | 3.177K |
| Dollar Volume | $423.14K |
Apogee Therapeutics News
1 week agoinvesting.comApogee Therapeutics, BitFuFu rise premarket; AbbVie gains after deal
- 1 week agoinvesting.com
AbbVie strikes $10.9 billion deal for Apogee Therapeutics
1 week agobarrons.comWhy AbbVie Is Spending $11 Billion to Buy Apogee Therapeutics
- 1 week agoinvesting.com
Why is Apogee Therapeutics stock surging today?
- 1 week agobarrons.com
S&P 500 Futures Fall in Premarket Trading; Apogee Therapeutics, Fervo Energy Lead
- 1 week agobarrons.com
Apogee Therapeutics Stock Soars. It’s Being Bought by AbbVie for $10.9 Billion.
- 1 week agobarrons.com
Intel, Micron, SpaceX, Apogee Therapeutics, and More Stocks That Explain Today’s Market
- 1 month agoinvesting.com
Apogee Therapeutics secures $1.3 billion Blackstone financing deal, shares dive
- 1 month agoinvesting.com
Apogee Therapeutics shares jump on $1.3B Blackstone deal
- 3 months agoinvesting.com
Apogee Therapeutics stock jumps on positive trial data
Apogee Therapeutics Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Apogee Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $132.67 |
|---|---|
| 10 Day Moving Average (SMA10) | $110.19 |
| 20 Day Moving Average (SMA20) | $97.19 |
| 50 Day Moving Average (SMA50) | $89.27 |
| 100 Day Moving Average (SMA100) | $81.56 |
| 200 Day Moving Average (SMA200) | $71.73 |
Apogee Therapeutics Statistics
| Average Volume (30 Days) | 3.79M |
|---|---|
| P/E Ratio (Current) | -36.35 |
| EPS (Current) | -$3.65 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$235.37M |
| Cash Ratio | 13.71 |
| Current Ratio | 32.59 |
| Quick Ratio | 32.59 |
| Debt to Equity | 0.00 |
| Enterprise Value | $9.52B |
| EV to EBITDA | -31.61 |
| EV to Sales | — |
| Price to Book | 7.94 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.21% |
| Return on Equity | -0.22% |
Apogee Therapeutics Stock Splits
There has been 1 stock split for Apogee Therapeutics (APGE). The reverse stock split occured on January 8, 2008 and reduced the outstanding shares at a ratio of 50:1.
| Date | Type | Ratio |
|---|---|---|
| Jan 8, 2008 | Reverse | 50:1 |
Apogee Therapeutics Dividends
There have been no dividends for Apogee Therapeutics (APGE).